Uranium's term price hits an all-time high — "bull market intact"
A macro-heavy 4th-of-July weekly: the liquidity/Cantillon lens on record-high valuations, "own hard assets you can't print," a new starter ARKG biotech position, the Strait-of-Hormuz oil "sugar rush," the uranium term price at $95.50/lb (an all-time high) with supply shutdowns from a sulfuric-acid shortage, Friedland's copper math, Latin America's right-wing rerating, food inflation from a super El Niño, and a new "cannibal" serial-buyback name.
In one line: money-printing keeps a floor under record valuations (Raoul Paul's ~97% liquidity/NASDAQ correlation; the Cantillon effect), so "own hard assets they can't create by fiat" — oil, gold, uranium. Uranium's June term price hit an all-time-high $95.50/lb with conversion and enrichment also at ATHs, while Orano (McClean Lake), Cameco (Cigar Lake) and Lotus (Kayelekera) all shut on a sulfuric-acid shortage traced back to the Gulf. He adds a starter ARKG biotech position on a bottoming chart (+73% YoY fund flow), likes Latin America on the left→right political rerating (Ecopetrol board purge; EC / GPRK / PXT as ways to watch it), warns of higher food prices into 2027 (super El Niño + fewest US wheat acres in 149 years), and teases a new "cannibal" serial-buyback name (Singleton/Teledyne, AZO as the exemplar).
1. Stocks & names mentioned
| Ticker | Name | Research | View | What he said | At |
| ARKG | ARK Genomic Revolution ETF | QT · SA · STK | Positive | "I've taken a position in the ARKG biotech fund." A new starter position taken because biotech indices have "either bottomed or broken higher on the charts" after ~7–8 years out of favor, with global biotech fund flow up 73% year-over-year; he isn't a biotech expert, so he's using the ETF to get exposure to a turning sector while AI-driven drug discovery could spill over. | 05:52 |
| SRUUF | Sprott Physical Uranium Trust (U.UN) | SA · STK | Positive | The June long-term (term) uranium price came in at $95.50/lb — "the highest term price ever" — and conversion and enrichment prices are also at all-time highs. "We are in a bull market that will continue until the necessary investments are made." Physical uranium remains a core holding and the bull thesis is reaffirmed. | 15:48 |
| CCJ | Cameco | QT · SA · STK · FA | Positive | Named in the uranium supply-woes item: "Cameco shuts down the world's largest uranium mine at Cigar Lake" — one of three simultaneous shutdowns (with Orano and Lotus) caused by sulfuric-acid shortages. Cited as bullish-supply context in a market he says is undersupplied and grinding higher. | 16:17 |
| EC | Ecopetrol | QT · SA · STK · FA | Neutral | Colombia's new right-wing president has decreed he will replace the board and management of state-controlled Ecopetrol, whose prior leadership stifled oil & gas investment until reserves declined. "Is it a buy? I don't know." Flagged as a regime-change rerating candidate to watch, not a call. | 24:47 |
| GPRK | GeoPark | QT · SA · STK · FA | Neutral | Named as an independent Colombian oil operator "you might want to look at" alongside Ecopetrol's board change — a private E&P that has partnered with Ecopetrol and could benefit from a more resource-friendly government. A watch idea, not a recommendation. | 25:56 |
| PXT | Parex Resources (TSX) | SA · STK · FA | Neutral | "Parex is another one that you might want to look at." A second independent Colombian oil operator named with GeoPark — independents that have partnered with Ecopetrol and could re-rate if the new government reopens exploration. A watch idea only. | 25:56 |
| AZO | AutoZone | QT · SA · STK · FA | Neutral | Cited as the exemplar "cannibal": "look at the performance of AutoZone over the last 20 or 30 years… it has consistently been cannibalizing its outstanding stock and buying back stock over time," which "helped propel the shares" and drive market outperformance. An illustration of the serial-buyback compounding he's studying — not a buy call. | 32:56 |
Stances reflect this weekly's framing only. A macro-heavy update: EC / GPRK / PXT are LatAm regime-change watch ideas (not stated holdings); AZO is an illustrative buyback exemplar. The "drug company" that is one of the portfolio's best performers, the "large copper miner in Africa" selling ~$1M/day of sulfuric acid, and the new "cannibal" permanent-capital vehicle (a Saudi family-office-backed name) were left unnamed and are intentionally not tickerized.
2. Talking points
00:56 — Record valuations & the liquidity lens ("Project Zimbabwe")
- Price-to-sales ratios are "the highest they've ever been" (Shiller / St. Louis Fed data). He's coming around to the idea that "we may be in Project Zimbabwe."
- Cites Raoul Paul's tweet showing liquidity is ~97% correlated with the NASDAQ — "in the short and medium-term, liquidity and sentiment drives stock prices," which explains much of the asset-price rise.
02:09 — Money-printing is the floor; the Cantillon effect
- "Money printing is now what the western democracies are wedded to because of the indebtedness" — a constant flow of new money has kept a floor under stocks and kept valuation metrics high since 2008.
- The Cantillon effect: created money has to go somewhere, and recipients push it into asset classes, making them expensive. Every crisis or disinflationary impulse is patched with printed money.
04:12 — "Own hard assets you can't print"
- His core takeaway: own things the Fed and government "can't create out of thin air… by fiat." More dollars/yen/euros don't translate into more oil, gold or uranium.
- Those assets have their own demand and fundamentals plus upward pressure from being priced in depreciating currencies.
05:52 — A starter biotech position (ARKG)
- "I've taken a position in the ARKG biotech fund." Biotech indices have "either bottomed or broken higher" after ~7–8 years out of favor; global biotech fund flow is up 73% year-over-year.
- He isn't a biotech expert, so he's using ETFs for a starter position, following experts, and betting AI/computing spills into drug discovery. The portfolio already holds an unnamed drug company that's "one of the best performers."
09:06 — Out-of-favor US regional/community banks
- He's looking at cheap US regional and small community banks — often founder-run, with the number of banks consolidating year after year. A thematic idea, no specific name.
- Adds to his existing out-of-favor themes: Latin America and Central Asia.
09:27 — The Strait of Hormuz "sugar rush"
- A chart of Strait-of-Hormuz transits shows a spike — "a chicken run, a prison break" of ships fleeing while they can, releasing tens of millions of barrels; one analyst called it "a sugar rush." Prices came down as a result.
- He reads the 60-day MOU as a political calculation by the Trump administration to get oil prices down and off the headlines — including easing sanctions to let Iran sell oil.
11:14 — "Kabuki theater" — not a lasting peace
- He calls the diplomacy a "Minsk agreement" — a temporary cooling to replenish armaments and "prepare for round two," not a durable peace between Israel and Iran.
- The MOU's bullet points (a $300B investment fund, a Gulf tolling arrangement) "won't come to fruition" — it's about getting crude to market and prices down before the US midterms, then rearming. "This is not over."
14:04 — China's demand is offline (for now)
- Gulf crude loadings are back to ~6–7 Mbpd vs ~20 Mbpd pre-war; "far from normalization."
- China has shrewdly stayed out of the market during the "meaty part of the conflict" — "if it wasn't for them… we probably would have had $150 oil." At some point they will reenter, another plate in the air.
15:48 — Uranium term price at an all-time high ($95.50)
- The June long-term (term) uranium price came in at $95.50/lb — "the highest term price ever." The bull market "continues slowly but surely, inching up month after month."
- Demand keeps increasing (another Chinese reactor went critical; SMRs in Idaho) while supply stays constrained; the billions in new-mine construction "are not there yet."
16:17 — Three uranium shutdowns on a sulfuric-acid shortage
- Per a John Quakes tweet: Orano shut the world's largest uranium mill (McClean Lake), Cameco (CCJ) shut the world's largest uranium mine (Cigar Lake), and Lotus indefinitely shut Kayelekera in Malawi — all three from sulfuric-acid shortages tied to acid-plant breakdowns and supply-chain issues.
- An undersupplied market getting tighter — supply woes keep piling up.
17:40 — The sulfuric-acid chain (Gulf → uranium & fertilizer)
- Gulf refining of heavy, high-sulfur crude produces the sulfur used to make sulfuric acid; military action limiting sulfur exports created the shortage. Prices spiked above 11,000 in June, back to ~9,000 — up 2.5–3× since hostilities began.
- A portfolio copper miner in Africa with a smelter was making "upwards of a million dollars a day" selling byproduct sulfuric acid to companies that need it. The shortage also hits phosphate-fertilizer processing — knock-on effects not yet resolved.
19:23 — Conversion & enrichment also at all-time highs
- North American conversion: long-term $55.50, spot $64. Enrichment (SWU): long-term up $4 to a new ATH of $180, spot $200.
- "All across the uranium supply chain you have all new all-time highs." Investment is being made in conversion/enrichment, but new greenfield mines are still missing — "where are they? Who's going to build them?"
20:58 — Friedland's copper math
- Echoing Robert Friedland (CEO, Ivanhoe): "we must mine as much copper in the next 25 years as in all of human history." ~700M tons mined over 10,000 years; another ~700M tons needed just at 3–3.5% GDP growth — and that excludes electrification.
- Add EVs, grids and AI and the University of Michigan models 1.1 billion tons by 2050 against just 23 million tons of annual mine supply. Lower grades and more dangerous jurisdictions set up a long-term bull market.
22:05 — Latin America's right-wing rerating
- Since Milei's election in Argentina, South America has swung from left- to right/center-right — from mostly-red in 2022 to right-wing across almost the whole Pacific coast, with Brazil's election in October (Lula "neck and neck").
- Left→right economic policy "can allow for a rerating of the stock market"; beaten-down markets have already rallied in anticipation. In Colombia the new president decreed replacing Ecopetrol's (EC) board/management; GeoPark (GPRK) and Parex (PXT) are independents to watch.
26:46 — LatAm cheap vs 20 years of US outperformance
- US stocks are at historic overvaluation while Latin American stocks are relatively cheap — and he sees an inflection in their relative performance just as political change turns the economies.
- The chart shows ~10-year cycles of LatAm out/underperformance vs the US; after almost 20 years of US outperformance, a decade-long rerating "can be a decade-long trend."
28:40 — Super El Niño & the fewest wheat acres in 149 years
- A possible "super El Niño" is coinciding with fertilizer not being applied and high diesel/fertilizer prices during planting — meaning less wheat production.
- The USDA projects US farmers will harvest just 32.1 million acres of wheat — "the fewest wheat acres in 149 years." With European heat, the Ukraine war and high input costs, he's "a little bit bullish" on food prices moving higher into 2027.
30:34 — A new "cannibal" for the newsletter (Singleton / Teledyne / AutoZone)
- He's adding a new company to the Actionable Intelligence Alert newsletter and has "become fond of cannibal stocks" — serial buyers of their own stock, citing Henry Singleton, who bought back ~90% of Teledyne over the 60s/70s.
- The new name: a management team he knew years ago that sold assets, paid down debt, and — with a large Saudi Arabian family office (non-royal) — created a "permanent capital vehicle" to roll up 5,000+ undervalued global cash-generating companies, buying back its own shares right after paying down debt. AutoZone (AZO) over 20–30 years is his example of how it can work. "We're not just about resources and commodities — we go anywhere to make money."
3. In plain English
ARKG — ARK Genomic Revolution ETF Positive
ARKG is a fund that owns a basket of biotech and gene-medicine companies. The whole sector has been unloved for roughly seven or eight years, so the stocks are cheap — and Polomny says the charts have finally stopped falling and started turning up, with money flowing back into biotech (fund inflows up 73% versus a year ago). He freely admits he's no expert in individual drug stocks, which is exactly why he buys the ETF: it's a low-effort "starter" way to own the sector's recovery without having to pick the one winning drug. His extra angle is that AI could speed up drug discovery, giving biotech a fresh tailwind. A small position in a bombed-out, turning sector — a "taste," not a big bet.
SRUUF — Sprott Physical Uranium Trust Positive
This trust simply holds physical uranium in storage, so its price tracks the uranium price rather than any single mining company. Polomny's point is that the long-term contract price utilities pay for uranium just hit an all-time high of $95.50 a pound, and the prices for turning that uranium into reactor fuel (conversion and enrichment) are at records too. Demand keeps rising as new reactors switch on, but new mines take many years and billions of dollars that haven't been spent yet — so supply can't catch up. That gap is why he stays long uranium: "a bull market that will continue until the necessary investments are made."
CCJ — Cameco Positive
Cameco is one of the world's biggest uranium miners. Here it comes up as a supply story rather than a stock pitch: Cameco just shut its Cigar Lake mine (the world's largest) at the same time France's Orano shut the world's largest processing mill and a mine in Malawi closed — all three tripped up by a shortage of sulfuric acid, a basic chemical needed to process ore. When the biggest producers go offline at once in a market that's already short of uranium, it tightens supply further and supports the whole uranium-bull thesis Polomny is playing.
EC — Ecopetrol Neutral
Ecopetrol is Colombia's government-controlled oil company. The outgoing left-wing government discouraged new oil and gas drilling to the point that Colombia's oil reserves have been shrinking. Now a new right-wing president says he'll replace Ecopetrol's board and management with people keen to develop the country's resources. Polomny's interest is the pattern — when a country swings from left to right, its beaten-down stock market can re-rate higher — but he's explicitly not making a call on the stock itself: "Is it a buy? I don't know." A situation to watch, not a recommendation.
GPRK — GeoPark Neutral
GeoPark is an independent oil producer that operates in Colombia and has partnered with Ecopetrol. Polomny names it as one of the smaller, privately run operators that could benefit if Colombia's new government reopens the country to oil and gas investment — you get exposure to the same political turnaround without owning the state-run giant. He offers it as something "you might want to look at," not a buy call.
PXT — Parex Resources Neutral
Parex Resources is another independent oil company focused on Colombia (listed in Canada). Like GeoPark, it partners with Ecopetrol and would stand to gain if a more resource-friendly Colombian government revives exploration and production. Polomny lists it alongside GeoPark as a name to research if you want to play Colombia's political shift through the nimbler independents rather than the state company. A watch idea only.
AZO — AutoZone Neutral
AutoZone sells car parts, but Polomny brings it up purely as a textbook "cannibal." A cannibal is a company that spends its cash steadily buying back and cancelling its own shares. Because the profits are then divided among fewer and fewer shares, each remaining share is worth more over time — even if the business itself only grows modestly. AutoZone has done this consistently for 20–30 years, which he says helped drive its stock's long outperformance. He uses it as the illustration of the serial-buyback strategy behind a new name he's adding to his newsletter — it's an example of the method, not a buy recommendation.
Built from the public YouTube weekly (see the clickable transcript) — stances and quotes are Polomny's own wording. For personal study — not investment advice.